Literature DB >> 7531897

Second Stanford Conference on International Standardization of Prostate-Specific Antigen Immunoassays: September 1 and 2, 1994.

T A Stamey1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7531897     DOI： 10.1016/0090-4295(95)80001-8

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  10 in total

1.  Prostate cancer: WHO standardization of PSA tests: clinical consequences.

Authors:  Carsten Stephan
Journal:  Nat Rev Urol       Date:  2009-06       Impact factor: 14.432

2.  Variability of assay methods for total and free PSA after WHO standardization.

Authors:  L Foj; X Filella; J Alcover; J M Augé; J M Escudero; R Molina
Journal:  Tumour Biol       Date:  2013-10-04

3.  The number of tPSA tests continues to rise and variation in testing practices persists: a survey of laboratory services in Ireland 2008-2010.

Authors:  F J Drummond; E Barrett; R Burns; C O'Neill; L Sharp
Journal:  Ir J Med Sci       Date:  2013-09-27       Impact factor: 1.568

4.  Equivalent recognition of free and ACT-complexed PSA in a monoclonal-polyclonal sandwich assay is conferred by binding specificity of the monoclonal antibody.

Authors:  Z Zhou; E G Armstrong; A Belenky; J V Freeman; K K Yeung
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

5.  Bayer Immuno 1 PSA Assay: an automated, ultrasensitive method to quantitate total PSA in serum.

Authors:  D L Morris; P W Dillon; D L Very; P Ng; L Kish; J L Goldblatt; D J Bruzek; D W Chan; M S Ahmed; D Witek; H A Fritsche; C Smith; D Schwartz; M K Schwartz; J L Noteboom; R L Vessella; K K Yeung; W J Allard
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

6.  The modified prostate health index (PHI) outperforms PHI density in the detection of clinical prostate cancer within the PSA grey zone.

Authors:  Haojie Chen; Bowen Shi; Yanyuan Wu; Yuhang Qian; Jiatong Zhou; Xi Zhang; Jie Ding; Yongjiang Yu
Journal:  Int Urol Nephrol       Date:  2022-02-24       Impact factor: 2.370

7.  Development and validation of a nomogram for predicting prostate cancer in men with prostate-specific antigen grey zone based on retrospective analysis of clinical and multi-parameter magnetic resonance imaging/transrectal ultrasound fusion-derived data.

Authors:  Zhimin Ding; Huaiyu Wu; Di Song; Hongtian Tian; Xiuqin Ye; Weiyu Liang; Yang Jiao; Jintao Hu; Jinfeng Xu; Fajin Dong
Journal:  Transl Androl Urol       Date:  2020-10

8.  Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.

Authors:  Mathilde His; Laurent Zelek; Mélanie Deschasaux; Camille Pouchieu; Emmanuelle Kesse-Guyot; Serge Hercberg; Pilar Galan; Paule Latino-Martel; Jacques Blacher; Mathilde Touvier
Journal:  Eur J Epidemiol       Date:  2014-02-13       Impact factor: 8.082

9.  Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.

Authors:  Mathilde Touvier; Léopold Fezeu; Namanjeet Ahluwalia; Chantal Julia; Nathalie Charnaux; Angela Sutton; Caroline Méjean; Paule Latino-Martel; Serge Hercberg; Pilar Galan; Sébastien Czernichow
Journal:  Am J Epidemiol       Date:  2012-11-20       Impact factor: 4.897

10.  Comparison of Three Assays for Total and Free PSA Using Hybritech and WHO Calibrations.

Authors:  Manuel M Garrido; José C Marta; Ruy M Ribeiro; Luís C Pinheiro; Stefan Holdenrieder; João T Guimarães
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.